Literature DB >> 15934779

Insights into the mechanism of action of ferroquine. Relationship between physicochemical properties and antiplasmodial activity.

Christophe Biot1, Donatella Taramelli, Isabelle Forfar-Bares, Lucien A Maciejewski, Mlandzeni Boyce, Guy Nowogrocki, Jacques S Brocard, Nicoletta Basilico, Piero Olliaro, Timothy J Egan.   

Abstract

Ferroquine (FQ) is a 4-aminoquinoline antimalarial which contains a quinoline nucleus similar to chloroquine, but a novel ferrocenic group in its side chain. Previous work has demonstrated that this compound has excellent activity against malaria parasites, both in vitro and in vivo, with especially good activity against chloroquine-resistant parasites, but details of its mechanism of action have not previously been reported. In this study, we have investigated the physicochemical properties of FQ for comparison with chloroquine (CQ). Like CQ, FQ forms complexes with hematin in solution (log K = 4.95 +/- 0.05). FQ is an even stronger inhibitor of beta-hematin formation than CQ (IC(50) = 0.78 equiv relative to hematin for FQ vs 1.9 for CQ). These data suggest that the mechanism of action of FQ is likely to be similar to that of CQ and probably involves hematin as the drug target and inhibition of hemozoin formation. However, both the basicity and lipophilicity of FQ are significantly different from those of CQ. The lipophilicity of FQ and CQ are similar when protonated at the putative food vacuole pH of 5.2 (log D = -0.77 and -1.2 respectively), but differ markedly at pH 7.4 (log D = 2.95 and 0.85 respectively). In addition, the pK(a) values of FQ are lower (pK(a1) = 8.19 and pK(a2) = 6.99) than those of CQ (10.03 and 7.94, respectively). This suggests that there will be somewhat less vacuolar accumulation of FQ compared with CQ. Single crystal structure determination of FQ shows the presence of a strong internal hydrogen bond between the 4-amino group and the terminal N atom. This, together with the electron donating properties of the ferrocene moiety, probably explains the decreased pK(a). Interestingly, the decreased accumulation arising from the less basic behavior of this compound is partly compensated for by its stronger beta-hematin inhibition. Increased lipophilicity, differences in geometric and electronic structure, and changes in the N-N distances in FQ compared to CQ probably explain its activity against CQ-resistant parasites.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15934779     DOI: 10.1021/mp0500061

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  22 in total

1.  Inhibitory activity of ferroquine, versus chloroquine, against western Kenya Plasmodium falciparum field isolates determined by a SYBR Green I in vitro assay.

Authors:  Fredrick L Eyase; Hoseah M Akala; Jacob D Johnson; Douglas S Walsh
Journal:  Am J Trop Med Hyg       Date:  2011-12       Impact factor: 2.345

2.  Speciation and structure of ferriprotoporphyrin IX in aqueous solution: spectroscopic and diffusion measurements demonstrate dimerization, but not mu-oxo dimer formation.

Authors:  Katherine A de Villiers; Catherine H Kaschula; Timothy J Egan; Helder M Marques
Journal:  J Biol Inorg Chem       Date:  2006-09-14       Impact factor: 3.358

3.  New Insights into the Understanding of Hepatitis C Virus Entry and Cell-to-Cell Transmission by Using the Ionophore Monensin A.

Authors:  Lucie Fénéant; Julie Potel; Catherine François; Famara Sané; Florian Douam; Sandrine Belouzard; Noémie Calland; Thibaut Vausselin; Yves Rouillé; Véronique Descamps; Thomas F Baumert; Gilles Duverlie; Dimitri Lavillette; Didier Hober; Jean Dubuisson; Czeslaw Wychowski; Laurence Cocquerel
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

Review 4.  A physico-biochemical study on potential redox-cyclers as antimalarial and anti-schistosomal drugs.

Authors:  Laure Johann; Don Antoine Lanfranchi; Elisabeth Davioud-Charvet; Mourad Elhabiri
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

5.  The mechanism of antimalarial action of [Au(CQ)(PPh(3))]PF(6): structural effects and increased drug lipophilicity enhance heme aggregation inhibition at lipid/water interfaces.

Authors:  Maribel Navarro; William Castro; Alberto Martínez; Roberto A Sánchez Delgado
Journal:  J Inorg Biochem       Date:  2010-11-13       Impact factor: 4.155

6.  Antiprotozoal activity of ferroquine.

Authors:  S Pomel; C Biot; C Bories; P M Loiseau
Journal:  Parasitol Res       Date:  2012-11-15       Impact factor: 2.289

7.  Discovery of dual function acridones as a new antimalarial chemotype.

Authors:  Jane X Kelly; Martin J Smilkstein; Reto Brun; Sergio Wittlin; Roland A Cooper; Kristin D Lane; Aaron Janowsky; Robert A Johnson; Rozalia A Dodean; Rolf Winter; David J Hinrichs; Michael K Riscoe
Journal:  Nature       Date:  2009-04-08       Impact factor: 49.962

8.  The antimalarial activity of Ru-chloroquine complexes against resistant Plasmodium falciparum is related to lipophilicity, basicity, and heme aggregation inhibition ability near water/n-octanol interfaces.

Authors:  Alberto Martínez; Chandima S K Rajapakse; Dalanda Jalloh; Cula Dautriche; Roberto A Sánchez-Delgado
Journal:  J Biol Inorg Chem       Date:  2009-04-03       Impact factor: 3.358

9.  In vitro activity of ferroquine is independent of polymorphisms in transport protein genes implicated in quinoline resistance in Plasmodium falciparum.

Authors:  Maud Henry; Sébastien Briolant; Albin Fontaine; Joel Mosnier; Eric Baret; Rémy Amalvict; Thierry Fusaï; Laurent Fraisse; Christophe Rogier; Bruno Pradines
Journal:  Antimicrob Agents Chemother       Date:  2008-05-27       Impact factor: 5.191

10.  The mechanism of antimalarial action of the ruthenium(II)-chloroquine complex [RuCl(2)(CQ)] (2).

Authors:  Alberto Martínez; Chandima S K Rajapakse; Becky Naoulou; Yasemin Kopkalli; Lesley Davenport; Roberto A Sánchez-Delgado
Journal:  J Biol Inorg Chem       Date:  2008-02-28       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.